158 related articles for article (PubMed ID: 38790547)
1. Epidemiology and Healthcare Utilization in Pediatric Multiple Sclerosis and Neuromyelitis Optica: A Nationwide Population-Based Study in South Korea (2016-2020).
Woo H; Hwang J; Choi SA; Chae SA
Children (Basel); 2024 May; 11(5):. PubMed ID: 38790547
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of pediatric multiple sclerosis, neuromyelitis optica, and optic neuritis in Taiwan.
Lin WS; Wang HP; Chen HM; Lin JW; Lee WT
J Neurol; 2020 Apr; 267(4):925-932. PubMed ID: 31781928
[TBL] [Abstract][Full Text] [Related]
3. Worldwide prevalence of neuromyelitis optica spectrum disorder (NMOSD) and neuromyelitis optica (NMO): a systematic review and meta-analysis.
Bagherieh S; Afshari-Safavi A; Vaheb S; Kiani M; Ghaffary EM; Barzegar M; Shaygannejad V; Zabeti A; Mirmosayyeb O
Neurol Sci; 2023 Jun; 44(6):1905-1915. PubMed ID: 36745300
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and comorbidities of adult multiple sclerosis and neuromyelitis optica in Taiwan, 2001-2015.
Fang CW; Wang HP; Chen HM; Lin JW; Lin WS
Mult Scler Relat Disord; 2020 Oct; 45():102425. PubMed ID: 32799120
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of Demyelinating Diseases in Korean Pediatric Patients.
Yoon HH; Park JY; Kim SY; Lee NM; Yi DY; Yun SW; Lim IS; Chae SA
J Child Neurol; 2021 Feb; 36(2):141-147. PubMed ID: 32988277
[TBL] [Abstract][Full Text] [Related]
6. Population-based Incidence of Pediatric and Adult Optic Neuritis and the Risk of Multiple Sclerosis.
Lee JY; Han J; Yang M; Oh SY
Ophthalmology; 2020 Mar; 127(3):417-425. PubMed ID: 31732227
[TBL] [Abstract][Full Text] [Related]
7. Specificities of Children with Multiple Sclerosis and Neuromyelitis Optica.
Fragoso YD
Cent Nerv Syst Agents Med Chem; 2018 Jan; 18(1):16-20. PubMed ID: 26654228
[TBL] [Abstract][Full Text] [Related]
8. Comparing epidemiology and baseline characteristic of multiple sclerosis and neuromyelitis optica: A case-control study.
Eskandarieh S; Nedjat S; Abdollahpour I; Moghadasi AN; Azimi AR; Sahraian MA
Mult Scler Relat Disord; 2017 Feb; 12():39-43. PubMed ID: 28283104
[TBL] [Abstract][Full Text] [Related]
9. A descriptive study of prevalence, clinical features and other findings of neuromyelitis optica and neuromyelitis optica spectrum disorder in Khuzestan Province, Iran.
Kashipazha D; Mohammadianinejad SE; Majdinasab N; Azizi M; Jafari M
Iran J Neurol; 2015 Oct; 14(4):204-10. PubMed ID: 26885339
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and incidence of neuromyelitis optica spectrum disorder and multiple sclerosis in Korea.
Kim JE; Park SH; Han K; Kim HJ; Shin DW; Kim SM
Mult Scler; 2020 Dec; 26(14):1837-1844. PubMed ID: 31749401
[TBL] [Abstract][Full Text] [Related]
11. Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report.
Chitnis T; Ness J; Krupp L; Waubant E; Hunt T; Olsen CS; Rodriguez M; Lotze T; Gorman M; Benson L; Belman A; Weinstock-Guttman B; Aaen G; Graves J; Patterson M; Rose JW; Casper TC
Neurology; 2016 Jan; 86(3):245-52. PubMed ID: 26683648
[TBL] [Abstract][Full Text] [Related]
12. Validation of claims-based diagnoses of adult and pediatric neuromyelitis optica spectrum disorder and variations in diagnostic evaluation and treatment initiation.
Gmuca S; Hardy DI; Narula S; Stoll S; Harris J; Zhao Y; Xiao R; Weiss PF; Waldman AT; Gerber JS
Mult Scler Relat Disord; 2020 Jan; 37():101488. PubMed ID: 31706167
[TBL] [Abstract][Full Text] [Related]
13. The impact of diagnostic criteria for neuromyelitis optica in patients with MS: a 10-year follow-up of the South Atlantic Project.
Papais-Alvarenga RM; Vasconcelos CC; Alves-Leon SV; Batista E; Santos CM; Camargo SM; Godoy M; Lacativa MC; Lorenti M; Damasceno B; Damasceno A; Brum D; Barreira AA; Guimarães Rocha MS; Alvarenga H; Tilbery CP
Mult Scler; 2014 Mar; 20(3):374-81. PubMed ID: 23970504
[TBL] [Abstract][Full Text] [Related]
14. Clinical and radiological profile of neuromyelitis optica spectrum disorders in a Pakistani cohort.
Rajput HM; Hassan M; Badshah M
Mult Scler Relat Disord; 2023 Jun; 74():104656. PubMed ID: 37068371
[TBL] [Abstract][Full Text] [Related]
15. Dynamic changes in patient admission and their disabilities in multiple sclerosis and neuromyelitis optica: A Japanese nationwide administrative data study.
Matsumoto Y; Tarasawa K; Misu T; Namatame C; Takai Y; Kuroda H; Fujihara K; Fushimi K; Fujimori K; Aoki M
Mult Scler Relat Disord; 2024 Jan; 81():105349. PubMed ID: 38043366
[TBL] [Abstract][Full Text] [Related]
16. Increased occurrence of anti-AQP4 seropositivity and unique HLA Class II associations with neuromyelitis optica (NMO), among Muslim Arabs in Israel.
Brill L; Mandel M; Karussis D; Petrou P; Miller K; Ben-Hur T; Karni A; Paltiel O; Israel S; Vaknin-Dembinsky A
J Neuroimmunol; 2016 Apr; 293():65-70. PubMed ID: 27049564
[TBL] [Abstract][Full Text] [Related]
17. Is Asian type MS an MS phenotype, an NMO spectrum disorder, or a MOG-IgG related disease?
Papais Alvarenga RM; Araújo ACRAE; Nascimento ACB; Araujo NEC; Meneguette NS; Neri VC; Papais Alvarenga M; Filho HA; Barros PO; Bento CA; Schmidt SL; Vasconcelos CCF; Alvarenga MP
Mult Scler Relat Disord; 2020 Jul; 42():102082. PubMed ID: 32361664
[TBL] [Abstract][Full Text] [Related]
18. Pediatric acquired demyelinating syndrome (ADS) in inpatient hospital settings: The hospitalization rate, costs, and outcomes in the US.
Minegishi M; Takahashi T; Testa M
Mult Scler Relat Disord; 2019 Sep; 34():150-157. PubMed ID: 31295724
[TBL] [Abstract][Full Text] [Related]
19. Clinical and laboratory features distinguishing MOG antibody disease from multiple sclerosis and AQP4 antibody-positive neuromyelitis optica.
Ciotti JR; Eby NS; Wu GF; Naismith RT; Chahin S; Cross AH
Mult Scler Relat Disord; 2020 Oct; 45():102399. PubMed ID: 32702642
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the spectrum of Korean inflammatory demyelinating diseases according to the diagnostic criteria and AQP4-Ab status.
Kim SM; Waters P; Woodhall M; Yang JW; Yang H; Kim JE; Sung JJ; Park KS; Lee KW
BMC Neurol; 2014 Apr; 14():93. PubMed ID: 24779645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
